$240.75 Nov 18, 2026 · market cap $35.2B
ResMed trades at $241. Our three models put it at $156–$309 (base $260): 8% below the base.
Cash Flow $309 · Buffett $260 · Damodaran $156 · models run Nov 18, 2026
9 of 121 tracked investors hold it · Q3 2026 13F filings
Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app